Article
Medicine, General & Internal
Marcin Kosmalski, Sylwia Ziolkowska, Piotr Czarny, Janusz Szemraj, Tadeusz Pietras
Summary: NAFLD and T2DM are closely related, with common risk factors and pathogenesis. Understanding the coexistence of NAFLD and T2DM can help prevent the occurrence of other diseases and improve quality of life.
JOURNAL OF CLINICAL MEDICINE
(2022)
Article
Endocrinology & Metabolism
Aya Bardugo, Cole D. Bendor, Inbar Zucker, Miri Lutski, Tali Cukierman-Yaffe, Estela Derazne, Ofri Mosenzon, Dorit Tzur, Zivan Beer, Orit Pinhas-Hamiel, Michal Ben-Ami, Boris Fishman, Dana Ben-Ami Shor, Itamar Raz, Arnon Afek, Hertzel C. Gerstein, Hans-Ulrich Haring, Amir Tirosh, Zohar Levi, Gilad Twig
Summary: A study found that among normoglycemic adolescents, nonalcoholic fatty liver disease (NAFLD) was associated with an increased risk for type 2 diabetes, which may manifest before the age of 30.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
(2021)
Article
Gastroenterology & Hepatology
Yoosun Cho, Yoosoo Chang, Seungho Ryu, Sarah H. Wild, Christopher D. Byrne
Summary: Reclassification of NAFLD as MAFLD has been proposed, and the risk of developing type 2 diabetes in NAFLD-only subjects remains unclear. This study compared the risk of incident T2D in individuals with NAFLD-only and MAFLD to those without fatty liver, and found that both NAFLD-only and MAFLD were associated with an increased risk of T2D. The risk was higher in women than in men, and the association was consistent across all subgroups.
LIVER INTERNATIONAL
(2023)
Article
Endocrinology & Metabolism
Yuetian Yu, Yuefeng Yu, Yuying Wang, Yi Chen, Ningjian Wang, Bin Wang, Yingli Lu
Summary: Nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM) are chronic multisystem diseases that cause significant health burdens worldwide. This study aimed to examine the causal relationship between NAFLD and T2DM. The findings suggest a causal effect of NAFLD on the development of T2DM, but the causal association between T2DM and NAFLD needs further verification.
FRONTIERS IN ENDOCRINOLOGY
(2023)
Article
Gastroenterology & Hepatology
Kimberly P. Newton, Laura A. Wilson, Nancy A. Crimmins, Mark H. Fishbein, Jean P. Molleston, Stavra A. Xanthakos, Cynthia Behling, Jeffrey B. Schwimmer
Summary: The study aimed to determine the incidence of type 2 diabetes (T2D) in children with nonalcoholic fatty liver disease (NAFLD) and identify associated risk factors. The results showed a high incidence rate of T2D in children with NAFLD, and being female, having a higher BMI z-score, and more severe liver histology were independent risk factors for T2D development.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
(2023)
Review
Gastroenterology & Hepatology
Eunji Ko, Eileen L. Yoon, Dae Won Jun
Summary: Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide, with an estimated prevalence of 25%. NAFLD is a major cause of liver cirrhosis, hepatocellular carcinoma, and death. Cardiovascular disease risk also increases with NAFLD severity.
CLINICAL AND MOLECULAR HEPATOLOGY
(2023)
Review
Endocrinology & Metabolism
Yuting Gao, Tianyi Zhao, Shuoning Song, Yanbei Duo, Junxiang Gao, Tao Yuan, Weigang Zhao
Summary: This meta-analysis found that lean nonalcoholic fatty liver disease (NAFLD) individuals have a higher risk of developing type 2 diabetes mellitus (T2DM), and this risk is associated with the severity of NAFLD.
DIABETES RESEARCH AND CLINICAL PRACTICE
(2023)
Article
Endocrinology & Metabolism
Shengjie Ge, Yinfeng Zheng, Linjia Du, Xiang Hu, Jingzong Zhou, Zhiying He, Xiao Gu, Xiaoyan Huang, Lijuan Yang, Xiuli Lin, Xuejiang Gu
Summary: The study found a negative association between follicle-stimulating hormone (FSH) and nonalcoholic fatty liver disease (NAFLD) in postmenopausal women with type 2 diabetes mellitus. FSH may be a potential index for screening and identifying individuals with a high risk of NAFLD in this group.
JOURNAL OF DIABETES
(2023)
Article
Medicine, General & Internal
Lisha Chen, Li Jiang
Summary: The study aims to analyze the clinicopathological features and risk factors of Type-2 diabetes mellitus (T2DM) patients with non-alcoholic fatty liver disease (NAFLD). The results showed that T2DM patients with NAFLD had higher BMI, hypertension, fasting plasma glucose (FPG), insulin resistance, triglycerides (TG), alanine aminotransferase (ALT), aspartate aminotransferase (AST), and uric acid (UA) levels. Further regression analysis identified high BMI, FPG, insulin resistance, and elevated TG as risk factors for T2DM with NAFLD.
PAKISTAN JOURNAL OF MEDICAL SCIENCES
(2022)
Article
Medicine, General & Internal
Qiumei Zhou, Yulong Wang, Jiajia Wang, Yating Liu, Dehui Qi, Wei Yao, Hui Jiang, Tingting Li, Kaiquan Huang, Wancun Zhang, Xingxing Huo
Summary: This study investigated the prevalence and risk factors for NAFLD in T2DM outpatients, revealing a prevalence rate of approximately 58.67% among T2DM patients. Eight significant predictors for NAFLD were identified through multivariate analysis, while CPI and C-Peptide showed high diagnostic value for NAFLD in T2DM patients.
Article
Endocrinology & Metabolism
Yifan Sun, Liang Hong, Zhe Huang, Lihong Wang, Yanqin Xiong, Shuhang Zong, Rui Zhang, Jun Liu, Shufei Zang
Summary: The study found that NAFLD, fibrosis, and type 2 diabetes had an additive interaction on chronic kidney disease incidence. The increased risk of NAFLD fibrosis was closely associated with chronic kidney disease in elderly patients with type 2 diabetes. FIB-4 performed better than NFS in predicting chronic kidney disease development.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
(2022)
Review
Medicine, Research & Experimental
Yifei Chen, Fuji Yang, Ying Chu, Zhihua Yun, Yongmin Yan, Jianhua Jin
Summary: Metabolic diseases, including obesity, diabetes, and nonalcoholic fatty liver disease, are increasing in incidence and prevalence, posing a major health and socioeconomic burden globally. While there is growing understanding of these diseases, effective treatments remain a challenge. Recent research suggests that mitochondrial dysfunction plays a role in the pathogenesis of metabolic diseases, and the use of healthy mitochondria as a therapeutic approach shows promise.
JOURNAL OF TRANSLATIONAL MEDICINE
(2022)
Article
Endocrinology & Metabolism
Yijiong Tan, Qin Zhen, Xiaoying Ding, Tingting Shen, Fang Liu, Yufan Wang, Qidi Zhang, Renkun Lin, Lili Chen, Yongde Peng, Nengguang Fan
Summary: This study found that the use of Liraglutide treatment is associated with a reduced risk of liver fibrosis in patients with type 2 diabetes.
FRONTIERS IN ENDOCRINOLOGY
(2022)
Review
Medicine, General & Internal
Cosmina-Theodora Diaconu, Cristian Guja
Summary: The prevalence of nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM) is rapidly increasing worldwide and has reached epidemic proportions. Based on common metabolic risk factors, their association poses an additional risk of hepatic and cardiovascular adverse outcomes. Appropriate terminology is important for the diagnosis and treatment of NAFLD. Strategies for addressing both diseases include lifestyle interventions, pharmacological options, and surgical procedures.
JOURNAL OF CLINICAL MEDICINE
(2022)
Article
Endocrinology & Metabolism
Nong Li, Weiting Xang, Shengli Wu, Danting Li, Min Chang, ChengYao Xie, Mei Yu Zhang, Huiwen Tan
Summary: This study aimed to explore the metabolic features of Lean-NAFLD and its association with the risk of incident type 2 diabetes in young and middle-aged people. The results showed that abdominal obesity is the strongest risk factor for type 2 diabetes in lean nonalcoholic fatty liver disease.
FRONTIERS IN ENDOCRINOLOGY
(2023)
Review
Cell Biology
Neelam Lohani, Nupur Bhargava, Anjana Munshi, Sivaprakash Ramalingam
JOURNAL OF CELLULAR PHYSIOLOGY
(2018)
Article
Oncology
Raman Preet Kaur, Rubal, Raja Paramjeet Singh Banipal, Rajesh Vashistha, Monisha Dhiman, Anjana Munshi
CURRENT PROBLEMS IN CANCER
(2019)
Review
Neurosciences
Kanika Vasudeva, Anjana Munshi
INTERNATIONAL JOURNAL OF NEUROSCIENCE
(2019)
Article
Biochemistry & Molecular Biology
Heena Singla, Raman Preet Kaur, Gowhar Shafi, Rajesh Vashistha, Raja Paramjeet Singh Banipal, Vinod Kumar, Anjana Munshi
MOLECULAR BIOLOGY REPORTS
(2019)
Article
Oncology
Raman Preet Kaur, Vicky Kumar, Gowhar Shafi, Rajesh Vashistha, Mahesh Kulharia, Anjana Munshi
Review
Neurosciences
Kanika Vasudeva, Anjana Munshi
EUROPEAN JOURNAL OF NEUROSCIENCE
(2020)
Review
Neurosciences
Abhilash Ludhiadch, Abhishek Muralidharan, Renuka Balyan, Anjana Munshi
INTERNATIONAL JOURNAL OF NEUROSCIENCE
(2020)
Review
Neurosciences
Abhilash Ludhiadch, Kanika Vasudeva, Anjana Munshi
INTERNATIONAL JOURNAL OF NEUROSCIENCE
(2020)
Review
Neurosciences
Kanika Vasudeva, Renuka Balyan, Anjana Munshi
NEUROMOLECULAR MEDICINE
(2020)
Review
Biochemistry & Molecular Biology
Prabhsimran Kaur, Sushil Kotru, Sandeep Singh, Bidwan Sekhar Behera, Anjana Munshi
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY
(2020)
Review
Oncology
Vikrant Mehta, Harish Chander, Anjana Munshi
Summary: This article highlights the potential role and importance of W. somnifera as a herbal medicine in the treatment of cancer, as well as its possible clinical application and research prospects.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
(2021)
Article
Neurosciences
Kanika Vasudeva, Anyeasha Dutta, Anjana Munshi
Summary: Stroke is a major cause of premature mortality and disability, with long non-coding RNAs (lncRNAs) emerging as significant players in the pathophysiology of cerebral ischemia. While very few lncRNAs have been functionally annotated, exploring their functions and mechanisms may lead to the development of promising treatment strategies.
MOLECULAR NEUROBIOLOGY
(2021)
Correction
Endocrinology & Metabolism
Khalid Khalaf Alharbi, Imran Ali Khan, Anjana Munshi, Fawiziah Khalaf Alharbi, Yazeed Al-Sheikh, May Salem Alnbaheen
Article
Dentistry, Oral Surgery & Medicine
G. Madhulatha, Satrupa Das, N. Venkateswarlu, Akhilesh Pujar, Akka Jyothy, Anjana Munshi
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY MEDICINE AND PATHOLOGY
(2018)
Article
Biochemistry & Molecular Biology
Sourav Kalra, Gaurav Joshi, Manvendra Kumar, Sahil Arora, Harsimrat Kaur, Sandeep Singh, Anjana Munshi, Raj Kumar
RSC MEDICINAL CHEMISTRY
(2020)